BARDA and NHLBI to hold blood, cell therapy symposium

The U.S. Biomedical Advanced Research and Development Authority and the U.S. National Heart, Lung and Blood Institute are hosting a major symposium on blood products and cellular therapies and their impact on emergency preparedness.

The meeting is to be held November 15-16 at the U.S. National Institutes of Health headquarters in Bethesda, Maryland.

Dr. Robin Robinson, BARDA's director, and Dr. W. Keith Hoots, the director of the Division of Blood Diseases and Resources at NHLBI, will be on hand to welcome attendees and orient them and provide an orientation to the two days worth of lectures and panel discussions.

Approximately 30 lectures are planned for the symposium, as well as a series of discussions to be held after each of the five major sessions - "Blood Products: Emergency Plans and Use," "Cellular Therapies with a Focus on Marrow Replacement," "Red Blood Cells and Plasma, Platelets and Pathogen Reduction."

BARDA is a component of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The agency is responsible for supporting the advanced research, development, manufacturing and the stockpiling of medical countermeasures, which include drugs, biological therapeutics, vaccines and diagnostics.

The NHLBI is part of the National Institutes of Health, the United States' national medical research system.

Organizations in this Story

National Institutes of Health

Want to get notified whenever we write about National Institutes of Health ?
Next time we write about National Institutes of Health, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.